Clinical trial
A Phase 1 Trial of Tolerability of Enteral N-Acetylcysteine in Infants
NCT06260566 is registered in ClinicalTrials.gov with Sanjiv Harpavat as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Trial of Tolerability of Enteral N-Acetylcysteine in Infants
- Lead sponsor
- Sanjiv Harpavat
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- October 31, 2026
- Completion date
- October 31, 2031
- Enrollment
- 12 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.